PITTSBURG – Texas Oncology today announced plans to open a new location in Pittsburg, Texas, adding a strategically located site to its growing practice in East Texas. The new location, expected to open in July, will occupy nearly 4,000 square feet of space at 408 Quitman Street in Pittsburg. Renovations at the site will begin later this month. When completed, Texas Oncology–Pittsburg will have a new infusion suite and four exam rooms, providing patients with medical oncology and hematology services, chemotherapy infusion and specialty infusion, radiation oncology consultations, as well as access to relevant clinical trials, and genetic risk evaluation and testing.
“At Texas Oncology, we are focused on enhancing access to high-quality cancer care closer to where patients live in communities across Texas – including in Pittsburg and the surrounding area of Camp, Titus, Franklin, and Morris counties,” said Steven Paulson, M.D., president and chairman of the board, Texas Oncology. “Patients in the Pittsburg area will receive personalized, leading-edge care, with a cancer care team connected to Texas Oncology’s vast network of oncology expertise and support services.”
The new location is an important addition to Texas Oncology’s significant presence and capabilities in East Texas, with comprehensive cancer centers in Paris and Longview, and in Tyler where the new Northeast Texas Cancer and Research Institute opened last November. Texas Oncology also has locations in Canton, Greenville, Jacksonville, Marshall, Mt. Vernon, Palestine, and Sulphur Springs.
In addition to on-site services such as medical oncology and hematology, patients receiving care in Pittsburg will have access to Texas Oncology’s wide range of multi-disciplinary care that includes some of the newest and innovative radiation therapies available such as intensity-modulated radiation therapy (IMRT), stereotactic body radiotherapy (SBRT), and brachytherapy procedures, all of which deliver radiation with greater precision to tumors, while avoiding nearby healthy tissue. Computed tomography (CT) and positron emission tomography (PET) imaging technologies also are available to help guide the diagnosis and administration of treatment with high-quality, clear images.
Following the conclusion of a 16-year collaboration with Titus Regional Medical Center, Texas Oncology’s location in Mount Pleasant will close at the end of June.
“We have served patients in East Texas for decades, and for more than 15 years in Mount Pleasant, and we are eager to continue providing care to patients in this area at our new Pittsburg location,” said Nayyar Syed, M.D., medical oncologist and hematologist at Texas Oncology. “Our priority is to provide community-based, high-quality care to patients in East Texas with access to innovative treatment and clinical trials, delivered in a cost-effective manner by a compassionate and dedicated care team.”
Texas Oncology has 30 physicians, 18 advanced practice providers, and nearly 400 additional clinical and support team members at 15 sites of service in East Texas – connected to a statewide network of more than 530 physicians and 6,000 employees. The Pittsburg location is part of a more than $150 million investment by Texas Oncology in capital improvements statewide over the past six years. The practice continues to grow with expanded colorectal, breast, and other surgical specialties, as well as offering more patients access to clinical trials, and a commitment to diagnostic and treatment innovations such as immunotherapy, biomarker testing, precision medicine, proton therapy radiation, and radiopharmaceuticals.